Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Ardea Biosciences reports positive results from a phase I hyperuricemia study

April 21, 2009

GlaxoSmithKline launches alli in Europe for weight loss

April 21, 2009

The European Commission withdraws marketing authorization for Velosulin

April 20, 2009

Bayer claims novel compounds for the treatment of dyslipidemia

April 20, 2009

DSMB recommends continuation of phase IIb study of Rockwell's SFP in ESRD

April 17, 2009

Diamyd to combine U.S. and European phase III trials of diabetes vaccine Diamyd

April 17, 2009

GENZ-112638 shows safety and efficacy in phase II trial for Gaucher's disease

April 17, 2009

Jenrin Discovery claims novel cannabinoid receptor antagonists

April 17, 2009

Tekmira files IND with FDA for phase I clinical trial of ApoB SNALP for LDL cholesterol

April 16, 2009

Rosuvastatin reduces high sensitivity C-reactive protein and LDLC

April 16, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...